New Eye Drops , May Help People , With Age-Related Vision Problems. 'The New York Times' reports that a new prescription eye-drop that improves close-range vision could help many people with age-related vision problems. .
Allergen's Vuity treats age-related vision loss, a condition called presbyopia.
.
According to 'The New York Times,' about 90% of adults over 45 in the U.S. suffer from presbyopia.
.
Dr. George O.
Waring IV, the medical director of the Waring Vision Institute, led Allergan's clinical trials for Vuity.
The results of the drug's Phase 3 clinical trials have not been published in a peer-reviewed journal.
.
In October, the drug was approved by the U.S. Food and Drug Administration.
Dr. Waring said that most health and vision insurance won't cover Vuity.
.
A 30-day supply costs about $80.
.
Dr. Scott M.
MacRae, an ophthalmologist at the University of Rochester’s Center for Visual Science, said that Vuity will work best for people with mild to moderate presbyopia.
.
'The New York Times' notes that Vuity does not work for nearsightedness, farsightedness or astigmatism.
.
Pilocarpine, the active ingredient of Vuity, has reportedly been used to treat glaucoma for decades
